This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Markovich, S.
Right arrow Articles by Osherov, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Markovich, S.
Right arrow Articles by Osherov, N.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2004, p. 3871-3876, Vol. 48, No. 10
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.10.3871-3876.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Genomic Approach to Identification of Mutations Affecting Caspofungin Susceptibility in Saccharomyces cerevisiae

Sarit Markovich,1 Aya Yekutiel,1 Itamar Shalit,1,2 Yona Shadkchan,1 and Nir Osherov1*

Sackler School of Medicine,1 Schneider Children's Medical Center of Israel Tel-Aviv University, Tel-Aviv, Israel2

Received 19 March 2004/ Returned for modification 16 April 2004/ Accepted 19 May 2004

The antifungal agent caspofungin (CAS) specifically interferes with glucan synthesis and cell wall formation. To further study the cellular processes affected by CAS, we analyzed a Saccharomyces cerevisiae mutant collection (4,787 individual knockout mutations) to identify new genes affecting susceptibility to the drug. This collection was screened for increased CAS sensitivity (CAS-IS) or increased CAS resistance (CAS-IR). MICs were determined by the broth microdilution method. Disruption of 20 genes led to CAS-IS (four- to eightfold reductions in the MIC). Eleven of the 20 genes are involved in cell wall and membrane function, notably in the protein kinase C (PKC) integrity pathway (MID2, FKS1, SMI1, and BCK1), chitin and mannan biosynthesis (CHS3, CHS4, CHS7, and MNN10), and ergosterol biosynthesis (ERG5 and ERG6). Four of the 20 genes (TPO1, VPS65, VPS25, and CHC1) are involved in vacuole and transport functions, 3 of the 20 genes (CCR4, POP2, and NPL3) are involved in the control of transcription, and 2 of the 20 genes are of unknown function. Disruption of nine additional genes led to CAS-IR (a fourfold increase of MIC). Five of these nine genes (SLG1, ERG3, VRP1, CSG2, and CKA2) are involved in cell wall function and signal transduction, and two of the nine genes (VPS67 and SAC2) are involved in vacuole function. To assess the specificity of susceptibility to CAS, the MICs of amphotericin B, fluconazole, flucytosine, and calcofluor for the strains were tested. Seven of 20 CAS-IS strains (with disruption of FKS1, SMI1, BCK1, CHS4, ERG5, TPO1, and ILM1) and 1 of 9 CAS-IR strains (with disruption of SLG1) demonstrated selective susceptibility to CAS. To further explore the importance of PKC in CAS susceptibility, the activity of the PKC inhibitor staurosporine in combination with CAS was tested against eight Aspergillus clinical isolates by the microdilution assay. Synergistic or synergistic-to-additive activities were found against all eight isolates by use of both MIC and minimum effective concentration endpoints.


* Corresponding author. Mailing address: Department of Human Microbiology, Sackler School of Medicine, Tel-Aviv University, Ramat-Aviv 69978, Tel-Aviv, Israel. Phone: 972-3-640-9599. Fax: 972-3-640-9160. E-mail: nosherov{at}post.tau.ac.il.


Antimicrobial Agents and Chemotherapy, October 2004, p. 3871-3876, Vol. 48, No. 10
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.10.3871-3876.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Dolan, K., Montgomery, S., Buchheit, B., DiDone, L., Wellington, M., Krysan, D. J. (2009). Antifungal Activity of Tamoxifen: In Vitro and In Vivo Activities and Mechanistic Characterization. Antimicrob. Agents Chemother. 53: 3337-3346 [Abstract] [Full Text]  
  • Garcia-Effron, G., Park, S., Perlin, D. S. (2009). Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints. Antimicrob. Agents Chemother. 53: 112-122 [Abstract] [Full Text]  
  • Hanaoka, N., Takano, Y., Shibuya, K., Fugo, H., Uehara, Y., Niimi, M. (2008). Identification of the Putative Protein Phosphatase Gene PTC1 as a Virulence-Related Gene Using a Silkworm Model of Candida albicans Infection. Eukaryot Cell 7: 1640-1648 [Abstract] [Full Text]  
  • Gonzalez-Ramos, D., Cebollero, E., Gonzalez, R. (2008). A Recombinant Saccharomyces cerevisiae Strain Overproducing Mannoproteins Stabilizes Wine against Protein Haze. Appl. Environ. Microbiol. 74: 5533-5540 [Abstract] [Full Text]  
  • Krysan, D. J., Didone, L. (2008). A High-Throughput Screening Assay for Small Molecules That Disrupt Yeast Cell Integrity. J Biomol Screen 13: 657-664 [Abstract]  
  • Cowen, L. E., Steinbach, W. J. (2008). Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance. Eukaryot Cell 7: 747-764 [Full Text]  
  • Chamilos, G., Lewis, R. E., Lamaris, G. A., Albert, N. D., Kontoyiannis, D. P. (2008). Genomewide Screening for Genes Associated with Gliotoxin Resistance and Sensitivity in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 52: 1325-1329 [Abstract] [Full Text]  
  • Cota, J. M., Grabinski, J. L., Talbert, R. L., Burgess, D. S., Rogers, P. D., Edlind, T. D., Wiederhold, N. P. (2008). Increases in SLT2 Expression and Chitin Content Are Associated with Incomplete Killing of Candida glabrata by Caspofungin. Antimicrob. Agents Chemother. 52: 1144-1146 [Abstract] [Full Text]  
  • Meletiadis, J., Stergiopoulou, T., O'Shaughnessy, E. M., Peter, J., Walsh, T. J. (2007). Concentration-Dependent Synergy and Antagonism within a Triple Antifungal Drug Combination against Aspergillus Species: Analysis by a New Response Surface Model. Antimicrob. Agents Chemother. 51: 2053-2064 [Abstract] [Full Text]  
  • Uemura, S., Kihara, A., Iwaki, S., Inokuchi, J.-i., Igarashi, Y. (2007). Regulation of the Transport and Protein Levels of the Inositol Phosphorylceramide Mannosyltransferases Csg1 and Csh1 by the Ca2+-binding Protein Csg2. J. Biol. Chem. 282: 8613-8621 [Abstract] [Full Text]  
  • Gonzalez, A., Ruiz, A., Serrano, R., Arino, J., Casamayor, A. (2006). Transcriptional Profiling of the Protein Phosphatase 2C Family in Yeast Provides Insights into the Unique Functional Roles of Ptc1. J. Biol. Chem. 281: 35057-35069 [Abstract] [Full Text]  
  • Lesage, G., Bussey, H. (2006). Cell Wall Assembly in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 70: 317-343 [Abstract] [Full Text]  
  • Hill, T. W., Loprete, D. M., Momany, M., Ha, Y., Harsch, L. M., Livesay, J. A., Mirchandani, A., Murdock, J. J., Vaughan, M. J., Watt, M. B. (2006). Isolation of cell wall mutants in Aspergillus nidulans by screening for hypersensitivity to Calcofluor White.. Mycologia 98: 399-409 [Abstract] [Full Text]  
  • Wiederhold, N. P., Kontoyiannis, D. P., Prince, R. A., Lewis, R. E. (2005). Attenuation of the Activity of Caspofungin at High Concentrations against Candida albicans: Possible Role of Cell Wall Integrity and Calcineurin Pathways. Antimicrob. Agents Chemother. 49: 5146-5148 [Abstract] [Full Text]